Emgality 300 MG (100 MG X3SYR)ML

Ended Awarded

Contract number
SPE2DX24FCQMK
Awardee
Awarding agency
Obligated
$1,495

Award facts

Contract value 100% obligated
$1,495.32 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Emgality 300 mg (100 mg x 3 syringes) medication. The contract has a ceiling value of $1,495.32 and a performance period through March 13, 2024. This award is a delivery order under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DX24FCQMK?

SPE2DX24FCQMK was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on March 12, 2024.

How much is contract SPE2DX24FCQMK worth?

The government has obligated $1,495 on SPE2DX24FCQMK.

Is contract SPE2DX24FCQMK an order under another contract?

Yes. SPE2DX24FCQMK is a delivery order under SPE2DX15D6044, an indefinite delivery contract.

Was contract SPE2DX24FCQMK competed?

The extent of competition for SPE2DX24FCQMK was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award